Highly potent API
Evonik can supply complex substances from grams to tons, with up to seven different HPAPI steps to be manufactured in parallel:
- A total capacity of 170m3 across two different sites in the U.S. and Europe
- Main site Tippecanoe Laboratories, Lafayette, IN, U.S.
- From lab scale up to 8,000l reactor volume
- OEL down to 0.1μg/m3 (large-scale)
- Small-scale production unit for ultra-HPAPI with an OEL down to 0.05μg/m3
Scope of Application
Highly potent active pharmaceutical ingredients (HPAPI) represent an increasingly significant share of the pharmaceutical drug pipeline including anti-cancer treatments.